Enterome vs Janux Therapeutics
Enterome vs Janux Therapeutics, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and Janux Therapeutics on 57/100.
Where each one leads
Enterome
- our overall score: 60/100 against 57/100
- domain rating: 46/100 against 39/100
- LinkedIn following: 16,846 against 12,449
Janux Therapeutics
- agent readiness: 42/100 against 21/100
- headcount: 110 against 33
- funding raised: $181M against $124M
At a glance
| Measure | Enterome | Janux Therapeutics |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | A clinical-stage biopharmaceutical company developing novel immunotherapies. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Pharmaceuticals, Healthcare, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Platform |
| Founded | 2012 | 2017 |
| Headquarters | Paris, France | San Diego, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | Enterome | Janux Therapeutics |
|---|---|---|
| Employees | 33 | 110 |
| Total funding | $124M | $181M |
| Latest round | Later Stage VC | Series B |
| Valuation | Not published | $1.1B |
| LinkedIn followers | 16,846 | 12,449 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | Janux Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 57/100 |
| Traction | 55/100 | 60/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 34/100 | 35/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 39/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | Janux Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Bootstrap | Jquery |
| Analytics | Google Analytics 4, Segment | Google Tag Manager |
Enterome vs Janux Therapeutics: common questions
Which is better, Enterome or Janux Therapeutics?
On our 0-100 score Enterome rates higher (60/100 against 57/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do Enterome and Janux Therapeutics compare on the numbers?
Enterome leads on our overall score (60/100 against 57/100), domain rating (46/100 against 39/100), LinkedIn following (16,846 against 12,449). Janux Therapeutics leads on agent readiness (42/100 against 21/100), headcount (110 against 33), funding raised ($181M against $124M).
Read the full Enterome review and pricing or the Janux Therapeutics review and pricing. You can also browse other Enterome alternatives we track.